Dec 14, 2022
6:5
For every 5 shares held, investors received 6. The price per share adjusted from $3735.00 to $3112.50.
The split itself did not change the total investment value.
Icure Pharmaceutical Incorporation (KRX:175250) operates in the Pharmaceuticals: major industry.
Icure Pharmaceutical Incorporation company overviewIcure Pharmaceutical Incorporation's most recent stock split was on December 14, 2022. It was a 6-for-5 forward split, so shareholders received 6 shares for every 5 they held.
Icure Pharmaceutical Incorporation (KRX:175250) has split its stock 4 times: a 6-for-5 split on March 8, 2021, a 2-for-1 split on December 6, 2021, a 449-for-386 split on October 21, 2022, and a 6-for-5 split on December 14, 2022.
Icure Pharmaceutical Incorporation has split its stock 4 times. This history records 4 forward splits between March 8, 2021 and December 14, 2022.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Icure Pharmaceutical Incorporation's 6-for-5 split on December 14, 2022, every 5 shares became 6 shares.
Icure Pharmaceutical Incorporation has not announced a new split in our records. Its most recent split was on December 14, 2022, 3 years ago. Companies announce splits in advance, and any new KRX:175250 split will appear on this page.
Already premium?